HELPP score study for pancreatic cancer outcomes
Part of Cancer clinical trials.
This study looks at a pretreatment score (called the HELPP score) to predict survival in people with localized pancreatic ductal adenocarcinoma. It may help doctors better estimate outcomes based on information gathered before treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have pancreatic ductal adenocarcinoma that has not spread to other organs (not metastatic)
- Your cancer treatment plan includes an elective pancreatic operation or palliative (comfort-focused) therapy
- You can provide informed consent (or already have)
- You have complete pretreatment lab test results and key clinical/pathology details on file
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tumor “markers” (tests on cancer tissue or related information) to understand how you may respond to first-line treatment for pancreatic cancer. Your results may help doctors better predict which treatments work best for different people.
This study looks at a scoring system to predict how well people with advanced pancreatic cancer might do after their first chemotherapy. If you have been diagnosed with this type of cancer and are about to start or have just finished your first treatment, this study may be able to use your health information to help guide future care.
This is a “registry” study that collects health information from adults with pancreatic ductal adenocarcinoma before starting treatment. It may help researchers better understand the disease and how patients are managed in real life.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
This trial studies an “implementation program” to help patients with locally advanced pancreatic cancer get ready for the next steps after chemotherapy. It may help improve care planning and outcomes for people whose cancer has not grown after initial treatment.
This trial tests a method that analyzes your tumor's genes and grows a mini-tumor in a dish to find which drugs might work best for your metastatic pancreatic cancer. It aims to improve treatment choices by using these personalized tests.
Hear when a new Pancreatic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.